{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06203600",
            "orgStudyIdInfo": {
                "id": "NCI-2023-11064"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2023-11064",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "S2303",
                    "type": "OTHER",
                    "domain": "SWOG"
                },
                {
                    "id": "S2303",
                    "type": "OTHER",
                    "domain": "CTEP"
                },
                {
                    "id": "U10CA180888",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/U10CA180888"
                }
            ],
            "organization": {
                "fullName": "National Cancer Institute (NCI)",
                "class": "NIH"
            },
            "briefTitle": "Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial",
            "officialTitle": "Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-L1 CPS &gt;/= 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMMUNE)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "adding-nivolumab-to-usual-treatment-for-people-with-advanced-stomach-or-esophageal-cancer-paramune-trial"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-10-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-10-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-10",
            "studyFirstSubmitQcDate": "2024-01-10",
            "studyFirstPostDateStruct": {
                "date": "2024-01-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "National Cancer Institute (NCI)",
                "class": "NIH"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.",
            "detailedDescription": "PRIMARY OBJECTIVES:\n\nI. To assess whether progression-free survival (PFS) is sufficiently improved in participants randomized to nivolumab + paclitaxel + ramucirumab compared to those randomized to paclitaxel + ramucirumab to warrant a phase III study with overall survival (OS) as the primary endpoint. (Phase II) II. To compare OS in participants randomized to nivolumab + paclitaxel + ramucirumab versus those randomized to paclitaxel + ramucirumab. (Phase III)\n\nSECONDARY OBJECTIVES:\n\nI. To compare PFS between those randomized to nivolumab + paclitaxel + ramucirumab versus those randomized to paclitaxel + ramucirumab. (Phase III) II. To compare OS between participants randomized to nivolumab + paclitaxel + ramucirumab compared to those randomized to paclitaxel + ramucirumab in the event that the trial is completed before the phase III portion.\n\nIII. To compare the overall response rate (ORR, including confirmed and unconfirmed, complete, and partial response, according to Response Evaluation Criteria in Solid Tumors \\[RECIST 1.1\\] criteria) between those randomized to nivolumab + paclitaxel + ramucirumab compared to those randomized to paclitaxel + ramucirumab among participants with measurable disease.\n\nIV. To compare the overall disease control rate (DCR = ORR + stable disease) between those randomized to nivolumab + paclitaxel + ramucirumab compared to those randomized to paclitaxel + ramucirumab among participants with measurable disease.\n\nV. To evaluate the safety and tolerability of each treatment regimen. VI. To compare health-related quality of life (QOL) by treatment arm at 8 weeks after randomization, measured using the Functional Assessment of Cancer Therapy - Gastric (FACT-Ga) Trial Outcome Index (TOI).\n\nVII. To compare health-related QOL between treatment arms at 8 weeks after randomization using the FACT-Ga total score.\n\nVIII. To compare longitudinal changes in health-related QOL between treatment arms using FACT-Ga TOI up to 24 weeks after randomization.\n\nIX. To compare patient-reported symptoms using selected Patient-Reported Outcomes-Common Terminology Criteria for Adverse Events (PRO-CTCAE) items including gastrointestinal as well as constitutional symptoms of fatigue, anorexia, and weight loss between treatment arms.\n\nOUTLINE: Patients are randomized to 1 of 2 arms.\n\nARM 1: Patients receive nivolumab intravenously (IV) over 30 minutes on day 1 of each cycle, ramucirumab IV over 30-60 minutes on days 1 and 15 of each cycle, and paclitaxel IV over 30 minutes on days 1, 8 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo computed tomography (CT) scan and magnetic resonance imaging (MRI) throughout the study. Patients may also optionally undergo blood sample collection on study.\n\nARM 2: Patients receive ramucirumab IV over 30-60 minutes on days 1 and 15 of each cycle and paclitaxel IV over 30 minutes on days 1, 8 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT scan and MRI throughout the study. Patients may also optionally undergo blood sample collection on study.\n\nAfter completion of study treatment, patients are followed up at 30, 60, 90 days and then every 6 months for up to 3 years."
        },
        "conditionsModule": {
            "conditions": [
                "Advanced Esophageal Adenocarcinoma",
                "Advanced Gastric Adenocarcinoma",
                "Advanced Gastroesophageal Junction Adenocarcinoma",
                "Clinical Stage II Esophageal Adenocarcinoma AJCC v8",
                "Clinical Stage III Esophageal Adenocarcinoma AJCC v8",
                "Clinical Stage III Gastric Cancer AJCC v8",
                "Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8",
                "Clinical Stage IV Esophageal Adenocarcinoma AJCC v8",
                "Clinical Stage IV Gastric Cancer AJCC v8",
                "Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8",
                "Metastatic Esophageal Adenocarcinoma",
                "Metastatic Gastric Adenocarcinoma",
                "Metastatic Gastroesophageal Junction Adenocarcinoma",
                "Unresectable Esophageal Adenocarcinoma",
                "Unresectable Gastric Adenocarcinoma",
                "Unresectable Gastroesophageal Junction Adenocarcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 224,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm 1 (nivolumab, ramucirumab, paclitaxel)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive nivolumab IV over 30 minutes on day 1 of each cycle, ramucirumab IV over 30-60 minutes on days 1 and 15 of each cycle, and paclitaxel IV over 30 minutes on days 1, 8 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT scan and MRI throughout the study. Patients may also optionally undergo blood sample collection on study.",
                    "interventionNames": [
                        "Procedure: Biospecimen Collection",
                        "Procedure: Computed Tomography",
                        "Procedure: Magnetic Resonance Imaging",
                        "Biological: Nivolumab",
                        "Drug: Paclitaxel",
                        "Other: Questionnaire Administration",
                        "Biological: Ramucirumab"
                    ]
                },
                {
                    "label": "Arm 2 (ramucirumab, paclitaxel)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Patients receive ramucirumab IV over 30-60 minutes on days 1 and 15 of each cycle and paclitaxel IV over 30 minutes on days 1, 8 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT scan and MRI throughout the study. Patients may also optionally undergo blood sample collection on study.",
                    "interventionNames": [
                        "Procedure: Biospecimen Collection",
                        "Procedure: Computed Tomography",
                        "Procedure: Magnetic Resonance Imaging",
                        "Drug: Paclitaxel",
                        "Other: Questionnaire Administration",
                        "Biological: Ramucirumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Biospecimen Collection",
                    "description": "Undergo optional blood sample collection",
                    "armGroupLabels": [
                        "Arm 1 (nivolumab, ramucirumab, paclitaxel)",
                        "Arm 2 (ramucirumab, paclitaxel)"
                    ],
                    "otherNames": [
                        "Biological Sample Collection",
                        "Biospecimen Collected",
                        "Specimen Collection"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Computed Tomography",
                    "description": "Undergo CT scan",
                    "armGroupLabels": [
                        "Arm 1 (nivolumab, ramucirumab, paclitaxel)",
                        "Arm 2 (ramucirumab, paclitaxel)"
                    ],
                    "otherNames": [
                        "CAT",
                        "CAT Scan",
                        "Computed Axial Tomography",
                        "Computerized Axial Tomography",
                        "Computerized axial tomography (procedure)",
                        "Computerized Tomography",
                        "Computerized Tomography (CT) scan",
                        "CT",
                        "CT Scan",
                        "tomography"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Magnetic Resonance Imaging",
                    "description": "Undergo MRI",
                    "armGroupLabels": [
                        "Arm 1 (nivolumab, ramucirumab, paclitaxel)",
                        "Arm 2 (ramucirumab, paclitaxel)"
                    ],
                    "otherNames": [
                        "Magnetic Resonance",
                        "Magnetic Resonance Imaging (MRI)",
                        "Magnetic resonance imaging (procedure)",
                        "Magnetic Resonance Imaging Scan",
                        "Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance",
                        "MR",
                        "MR Imaging",
                        "MRI",
                        "MRI Scan",
                        "MRIs",
                        "NMR Imaging",
                        "NMRI",
                        "Nuclear Magnetic Resonance Imaging",
                        "sMRI",
                        "Structural MRI"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Nivolumab",
                    "description": "Given IV",
                    "armGroupLabels": [
                        "Arm 1 (nivolumab, ramucirumab, paclitaxel)"
                    ],
                    "otherNames": [
                        "ABP 206",
                        "BCD-263",
                        "BMS 936558",
                        "BMS-936558",
                        "BMS936558",
                        "CMAB819",
                        "MDX 1106",
                        "MDX-1106",
                        "MDX1106",
                        "NIVO",
                        "Nivolumab Biosimilar ABP 206",
                        "Nivolumab Biosimilar BCD-263",
                        "Nivolumab Biosimilar CMAB819",
                        "ONO 4538",
                        "ONO-4538",
                        "ONO4538",
                        "Opdivo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Paclitaxel",
                    "description": "Given IV",
                    "armGroupLabels": [
                        "Arm 1 (nivolumab, ramucirumab, paclitaxel)",
                        "Arm 2 (ramucirumab, paclitaxel)"
                    ],
                    "otherNames": [
                        "Anzatax",
                        "Asotax",
                        "Bristaxol",
                        "Praxel",
                        "Taxol",
                        "Taxol Konzentrat"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Questionnaire Administration",
                    "description": "Ancillary studies",
                    "armGroupLabels": [
                        "Arm 1 (nivolumab, ramucirumab, paclitaxel)",
                        "Arm 2 (ramucirumab, paclitaxel)"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Ramucirumab",
                    "description": "Given IV",
                    "armGroupLabels": [
                        "Arm 1 (nivolumab, ramucirumab, paclitaxel)",
                        "Arm 2 (ramucirumab, paclitaxel)"
                    ],
                    "otherNames": [
                        "Anti-VEGFR-2 Fully Human Monoclonal Antibody IMC-1121B",
                        "Cyramza",
                        "IMC 1121B",
                        "IMC-1121B",
                        "IMC1121B",
                        "LY 3009806",
                        "LY-3009806",
                        "LY3009806",
                        "Monoclonal Antibody HGS-ETR2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Progression free survival (PFS) (Phase II)",
                    "description": "The distribution of PFS will be estimated using the method of Kaplan-Meier and compared using a 1-sided stratified log-rank test.",
                    "timeFrame": "From date of randomization to date of first documentation of progression or symptomatic deterioration or death due to any cause, assessed up to 3 years"
                },
                {
                    "measure": "Overall survival (OS) (Phase III)",
                    "description": "The distribution of OS will be estimated using the method of Kaplan-Meier and compared using a 1-sided stratified log-rank test.",
                    "timeFrame": "From date of randomization to date of death due to any cause, assessed up to 3 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Objective response rate (ORR)",
                    "description": "Will be compared across arms in participants with measurable disease via Fisher's exact test.",
                    "timeFrame": "Up to 3 years"
                },
                {
                    "measure": "Disease control rate (DCR)",
                    "description": "DCR = ORR + stable disease per Response Evaluation Criteria in Solid Tumors 1.1. Will be compared across arms in participants with measurable disease via Fisher's exact test.",
                    "timeFrame": "Up to 3 years"
                },
                {
                    "measure": "Incidence of adverse events",
                    "timeFrame": "Up to 3 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Disease-free survival (DFS)",
                    "description": "The hazard ratio of DFS and the corresponding 95% confidence intervals will be estimated for subgroups defined by sex, race, and ethnicity, respectively.",
                    "timeFrame": "Up to 3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants must have advanced or locally unresectable gastric, gastroesophageal junction or esophageal adenocarcinoma\n* Participants must have PD-L1 CPS (Combined Positive Score) \u2265 1. This test would have been performed as part of standard of care (SOC) pathology testing, using tissue obtained within two years prior to registration and collected prior to or after a frontline regimen\n* Participants must have a histologically confirmed diagnosis of microsatellite stable (MSS) and HER2 negative gastric, gastroesophageal junction, or esophageal adenocarcinoma\n* Participants must have documented unresectable and/or metastatic disease on CT or MRI imaging completed prior to registration. Imaging must have been completed within 28 days prior to registration for participants with measurable disease. CT scans or MRIs used to assess non-measurable disease must have been completed within 42 days prior to registration. All disease must be assessed and documented on the Baseline Tumor Assessment Form\n* Participants with treated brain metastases must have no evidence of progression on the follow-up brain imaging after central nervous system (CNS)-directed therapy. All treatment for brain metastases must have been completed at least 28 days prior to registration\n* Participants must have disease progression or intolerance to frontline standard of care (SOC) chemotherapy plus either nivolumab, pembrolizumab or any other PD-1 or PD-L1 inhibitor. Peri-operative chemotherapy plus nivolumab, pembrolizumab or any other PD-1 or PD-L1 inhibitor will count as one line if disease progression occurs while on the therapy or within 6 months of completing the chemotherapy plus nivolumab or pembrolizumab or other PD-1/PD-L1 inhibitor cycle\n* Participants must not have received more than one prior line of systemic therapy\n* Participants must not have a condition requiring systemic treatment with either corticosteroids (\\> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of registration. Inhaled or topical steroids and adrenal replacement doses \\< 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease. Participants are permitted to use topical, ocular, intra-articular, intranasal, and inhalational corticosteroids (with minimal systemic absorption). Physiologic replacement doses of systemic corticosteroids are permitted, even if \\< 10 mg/day prednisone equivalents. A brief course of corticosteroids for prophylaxis (e.g., contrast dye allergy) or for treatment of non-autoimmune conditions (e.g., delayed-type hypersensitivity reaction caused by contact allergen) is permitted, as long as there has been a washout period for corticosteroids of \u2265 7 days prior to registration\n* Participants must not have prior significant immunotherapy related adverse events requiring permanent discontinuation of the immunotherapy agent including events like pneumonitis, myocarditis, renal failure, Guillain barre syndrome, or myasthenia gravis. Participants with endocrinopathy events leading or not to replacement steroids, thyroid hormone, insulin, or cortisol are eligible\n* Participants must not have received a live attenuated vaccination within 28 days prior to registration\n* Participants must not have had a major surgery within 28 days or subcutaneous venous access device placement within 7 days prior registration\n* Participants must have fully recovered from the effects of prior surgery in the opinion of the treating investigator. Any participants with postoperative bleeding complications or wound complications from a surgical procedure performed in the last eight weeks should be excluded\n* Participants must not have plans to undergo elective or planned major surgery during the clinical trial\n* Participants must not have active bleeding or prior history of gastrointestinal (GI) perforation, fistula or significant GI bleeding (requiring transfusion, endoscopic or surgical intervention) within 84 days prior to registration\n* Participants must not be planning to receive any concurrent chemotherapy, immunotherapy, investigational agents, biologic or hormonal therapy for cancer treatment while receiving treatment on this study\n* Participants must not have a history of a grade 3 or 4 allergic reaction attributed to humanized or human monoclonal antibody therapy\n* Participants must not have a history of grade 3 or 4 immunotherapy related toxicities with the exception of hormonal abnormalities like thyroiditis or thyroid derangements\n* Participants must be \u2265 18 years old\n* Participants must have Zubrod Performance Status of 0-2\n* Participants must have a complete medical history and physical exam within 28 days prior to registration\n* Leukocytes \u2265 2 x 10\\^3/uL within 28 days prior to registration\n* Absolute neutrophil count \u2265 1.2 x 10\\^3/uL within 28 days prior to registration\n* Hemoglobin \u2265 9.0 g/dL within 28 days prior to registration\n* Platelets \u2265 100 x 10\\^3/uL within 28 days prior to registration\n* Total bilirubin \u2264 1.5 x institutional upper limit of normal (ULN) (within 28 days prior to registration) unless history of Gilbert's disease. Participants with history of Gilbert's disease must have total bilirubin \u2264 5 x institutional ULN\n* Aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) \u2264 3 \u00d7 institutional ULN (within 28 days prior to registration) (unless liver metastases are present, in which case they must be \u2264 5 x ULN)\n* Participants must have a creatinine \u2264 1.5 x the institutional ULN OR calculated creatinine clearance \u2265 40 mL/min using the following Cockcroft-Gault Formula. This specimen must have been drawn and processed within 28 days prior to registration\n* Participants' urinary protein must be \u2264 1+ on dipstick or routine urinalysis (UA) within 28 days of registration. Random analysis of urine protein with a normal value is sufficient. If urine dipstick or routine analysis indicated proteinuria \u2265 2+, then a 24-hour urine is to be collected and demonstrate \\< 1000 mg of protein in 24 hours to allow participation in the study\n* Participants must have adequate cardiac function. Participants with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, must have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, participants must be class 2 or better\n* Participants must have recovered to baseline or \\< grade 2 CTCAE version (v) 5.0 from toxicities related to any prior treatments, unless AE(s) are clinically stable on supportive therapy\n* Participants must not have experienced arterial thromboembolic events, including but not limited to myocardial infarction, transient ischemic attack, cerebrovascular accident, or unstable angina, within 6 months prior to registration\n* Participants must not have uncontrolled blood pressure within 28 days prior to registration as determined by the treating investigator\n* Participants with known human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy at registration and have undetectable viral load on the most recent test results obtained within 6 months prior to registration\n* Participants with evidence of chronic hepatitis B virus (HBV) infection must have undetectable HBV viral load while on suppressive therapy on the most recent test results obtained within 6 months prior to registration, if indicated\n* Participants with a history of hepatitis C virus (HCV) infection must have been treated and cured. Participants currently being treated for HCV infection must have undetectable HCV viral load on the most recent test results obtained within 6 months prior to registration, if indicated\n* Participants must not have a prior or concurrent malignancy whose natural history or treatment (in the opinion of the treating physician) has the potential to interfere with the safety or efficacy assessment of the investigational regimen\n* Participants must not be pregnant or nursing (nursing includes breast milk fed to an infant by any means, including from the breast, milk expressed by hand, or pumped). Individuals who are of reproductive potential must have agreed to use an effective contraceptive method with details provided as a part of the consent process. A person who has had menses at any time in the preceding 12 consecutive months or who has semen likely to contain sperm is considered to be of \"reproductive potential.\" In addition to routine contraceptive methods, \"effective contraception\" also includes refraining from sexual activity that might result in pregnancy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) including hysterectomy, bilateral oophorectomy, bilateral tubal ligation/occlusion, and vasectomy with testing showing no sperm in the semen\n* Participants must not have a history of inflammatory bowel disease, (including ulcerative colitis and Crohn's disease), symptomatic autoimmune disease (e.g., rheumatoid arthritis, systemic progressive sclerosis \\[scleroderma\\], systemic lupus erythematosus, autoimmune vasculitis \\[e.g., Wegener's Granulomatosis\\]); CNS or motor neuropathy considered of autoimmune origin (e.g., Guillain-Barre Syndrome and myasthenia gravis, multiple sclerosis). Note: Participants with Graves' disease will be allowed\n* Participants must not have a history of pneumonitis that has required oral or IV steroids within the last 12 months prior to registration\n* Participants must be offered the opportunity to participate in specimen banking. With participant consent, specimens must be collected and submitted via the Southwest Oncology Group (SWOG) Specimen Tracking System\n* Participants who can complete patient reported outcomes (FACT-Ga and PRO-CTCAE) questionnaires in English or Spanish must participate in the quality of life studies\n* Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines. For participants with impaired decision-making capabilities, legally authorized representatives may sign and give informed consent on behalf of study participants in accordance with applicable federal, local, and Central Institutional Review Board (CIRB) regulations",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Anwaar Saeed",
                    "affiliation": "SWOG Cancer Research Network",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Helen F Graham Cancer Center",
                    "status": "RECRUITING",
                    "city": "Newark",
                    "state": "Delaware",
                    "zip": "19713",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "302-623-4450",
                            "email": "lbarone@christianacare.org"
                        },
                        {
                            "name": "Gregory A. Masters",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.68372,
                        "lon": -75.74966
                    }
                },
                {
                    "facility": "Medical Oncology Hematology Consultants PA",
                    "status": "RECRUITING",
                    "city": "Newark",
                    "state": "Delaware",
                    "zip": "19713",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "302-623-4450",
                            "email": "lbarone@christianacare.org"
                        },
                        {
                            "name": "Gregory A. Masters",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.68372,
                        "lon": -75.74966
                    }
                },
                {
                    "facility": "Illinois CancerCare-Bloomington",
                    "status": "RECRUITING",
                    "city": "Bloomington",
                    "state": "Illinois",
                    "zip": "61704",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4842,
                        "lon": -88.99369
                    }
                },
                {
                    "facility": "Illinois CancerCare-Canton",
                    "status": "RECRUITING",
                    "city": "Canton",
                    "state": "Illinois",
                    "zip": "61520",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.55809,
                        "lon": -90.03512
                    }
                },
                {
                    "facility": "Illinois CancerCare-Carthage",
                    "status": "RECRUITING",
                    "city": "Carthage",
                    "state": "Illinois",
                    "zip": "62321",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.91892,
                        "lon": -89.31371
                    }
                },
                {
                    "facility": "Cancer Care Specialists of Illinois - Decatur",
                    "status": "RECRUITING",
                    "city": "Decatur",
                    "state": "Illinois",
                    "zip": "62526",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "217-876-4762",
                            "email": "morganthaler.jodi@mhsil.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.84031,
                        "lon": -88.9548
                    }
                },
                {
                    "facility": "Decatur Memorial Hospital",
                    "status": "RECRUITING",
                    "city": "Decatur",
                    "state": "Illinois",
                    "zip": "62526",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "217-876-4762",
                            "email": "morganthaler.jodi@mhsil.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.84031,
                        "lon": -88.9548
                    }
                },
                {
                    "facility": "Illinois CancerCare-Dixon",
                    "status": "RECRUITING",
                    "city": "Dixon",
                    "state": "Illinois",
                    "zip": "61021",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "815-285-7800"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.83892,
                        "lon": -89.47955
                    }
                },
                {
                    "facility": "Crossroads Cancer Center",
                    "status": "RECRUITING",
                    "city": "Effingham",
                    "state": "Illinois",
                    "zip": "62401",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "217-876-4762",
                            "email": "morganthaler.jodi@mhsil.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12004,
                        "lon": -88.54338
                    }
                },
                {
                    "facility": "Illinois CancerCare-Eureka",
                    "status": "RECRUITING",
                    "city": "Eureka",
                    "state": "Illinois",
                    "zip": "61530",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.72143,
                        "lon": -89.27286
                    }
                },
                {
                    "facility": "Illinois CancerCare-Galesburg",
                    "status": "RECRUITING",
                    "city": "Galesburg",
                    "state": "Illinois",
                    "zip": "61401",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.94782,
                        "lon": -90.37124
                    }
                },
                {
                    "facility": "Illinois CancerCare-Kewanee Clinic",
                    "status": "RECRUITING",
                    "city": "Kewanee",
                    "state": "Illinois",
                    "zip": "61443",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.24559,
                        "lon": -89.92483
                    }
                },
                {
                    "facility": "Illinois CancerCare-Macomb",
                    "status": "RECRUITING",
                    "city": "Macomb",
                    "state": "Illinois",
                    "zip": "61455",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.45921,
                        "lon": -90.6718
                    }
                },
                {
                    "facility": "Illinois CancerCare-Ottawa Clinic",
                    "status": "RECRUITING",
                    "city": "Ottawa",
                    "state": "Illinois",
                    "zip": "61350",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.34559,
                        "lon": -88.84258
                    }
                },
                {
                    "facility": "Illinois CancerCare-Pekin",
                    "status": "RECRUITING",
                    "city": "Pekin",
                    "state": "Illinois",
                    "zip": "61554",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.56754,
                        "lon": -89.64066
                    }
                },
                {
                    "facility": "Illinois CancerCare-Peoria",
                    "status": "RECRUITING",
                    "city": "Peoria",
                    "state": "Illinois",
                    "zip": "61615",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.69365,
                        "lon": -89.58899
                    }
                },
                {
                    "facility": "Illinois CancerCare-Peru",
                    "status": "RECRUITING",
                    "city": "Peru",
                    "state": "Illinois",
                    "zip": "61354",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.32753,
                        "lon": -89.12897
                    }
                },
                {
                    "facility": "Illinois CancerCare-Princeton",
                    "status": "RECRUITING",
                    "city": "Princeton",
                    "state": "Illinois",
                    "zip": "61356",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.36809,
                        "lon": -89.46481
                    }
                },
                {
                    "facility": "Memorial Hospital East",
                    "status": "RECRUITING",
                    "city": "Shiloh",
                    "state": "Illinois",
                    "zip": "62269",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "314-747-9912",
                            "email": "dschwab@wustl.edu"
                        },
                        {
                            "name": "Patrick Grierson",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.56144,
                        "lon": -89.89732
                    }
                },
                {
                    "facility": "Southern Illinois University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Springfield",
                    "state": "Illinois",
                    "zip": "62702",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "217-545-7929"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.80172,
                        "lon": -89.64371
                    }
                },
                {
                    "facility": "Illinois CancerCare - Washington",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "Illinois",
                    "zip": "61571",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "309-243-3605",
                            "email": "andersonj@illinoiscancercare.com"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.70365,
                        "lon": -89.40731
                    }
                },
                {
                    "facility": "Mercy Hospital",
                    "status": "RECRUITING",
                    "city": "Cedar Rapids",
                    "state": "Iowa",
                    "zip": "52403",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "319-365-4673"
                        },
                        {
                            "name": "Deborah W. Wilbur",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.00833,
                        "lon": -91.64407
                    }
                },
                {
                    "facility": "Oncology Associates at Mercy Medical Center",
                    "status": "RECRUITING",
                    "city": "Cedar Rapids",
                    "state": "Iowa",
                    "zip": "52403",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "319-363-2690"
                        },
                        {
                            "name": "Deborah W. Wilbur",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.00833,
                        "lon": -91.64407
                    }
                },
                {
                    "facility": "Trinity Health Saint Joseph Mercy Hospital Ann Arbor",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "734-712-7251",
                            "email": "MCRCwebsitecontactform@stjoeshealth.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Trinity Health IHA Medical Group Hematology Oncology - Brighton",
                    "status": "RECRUITING",
                    "city": "Brighton",
                    "state": "Michigan",
                    "zip": "48114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "734-712-7251",
                            "email": "MCRCwebsitecontactform@stjoeshealth.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.52948,
                        "lon": -83.78022
                    }
                },
                {
                    "facility": "Trinity Health Medical Center - Brighton",
                    "status": "RECRUITING",
                    "city": "Brighton",
                    "state": "Michigan",
                    "zip": "48114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "734-712-7251",
                            "email": "MCRCwebsitecontactform@stjoeshealth.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.52948,
                        "lon": -83.78022
                    }
                },
                {
                    "facility": "Trinity Health IHA Medical Group Hematology Oncology - Canton",
                    "status": "RECRUITING",
                    "city": "Canton",
                    "state": "Michigan",
                    "zip": "48188",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "734-712-7251",
                            "email": "MCRCwebsitecontactform@stjoeshealth.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.30865,
                        "lon": -83.48216
                    }
                },
                {
                    "facility": "Trinity Health Medical Center - Canton",
                    "status": "RECRUITING",
                    "city": "Canton",
                    "state": "Michigan",
                    "zip": "48188",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "734-712-7251",
                            "email": "MCRCwebsitecontactform@stjoeshealth.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.30865,
                        "lon": -83.48216
                    }
                },
                {
                    "facility": "Chelsea Hospital",
                    "status": "RECRUITING",
                    "city": "Chelsea",
                    "state": "Michigan",
                    "zip": "48118",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "734-712-7251",
                            "email": "MCRCwebsitecontactform@stjoeshealth.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.31807,
                        "lon": -84.02181
                    }
                },
                {
                    "facility": "Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital",
                    "status": "RECRUITING",
                    "city": "Chelsea",
                    "state": "Michigan",
                    "zip": "48118",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "734-712-7251",
                            "email": "MCRCwebsitecontactform@stjoeshealth.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.31807,
                        "lon": -84.02181
                    }
                },
                {
                    "facility": "Genesee Cancer and Blood Disease Treatment Center",
                    "status": "RECRUITING",
                    "city": "Flint",
                    "state": "Michigan",
                    "zip": "48503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "810-762-8038",
                            "email": "wstrong@ghci.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.01253,
                        "lon": -83.68746
                    }
                },
                {
                    "facility": "Genesee Hematology Oncology PC",
                    "status": "RECRUITING",
                    "city": "Flint",
                    "state": "Michigan",
                    "zip": "48503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "810-762-8038",
                            "email": "wstrong@ghci.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.01253,
                        "lon": -83.68746
                    }
                },
                {
                    "facility": "Genesys Hurley Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Flint",
                    "state": "Michigan",
                    "zip": "48503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "810-762-8038",
                            "email": "wstrong@ghci.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.01253,
                        "lon": -83.68746
                    }
                },
                {
                    "facility": "Hurley Medical Center",
                    "status": "RECRUITING",
                    "city": "Flint",
                    "state": "Michigan",
                    "zip": "48503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "810-762-8038",
                            "email": "wstrong@ghci.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.01253,
                        "lon": -83.68746
                    }
                },
                {
                    "facility": "Trinity Health Saint Mary Mercy Livonia Hospital",
                    "status": "RECRUITING",
                    "city": "Livonia",
                    "state": "Michigan",
                    "zip": "48154",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "734-712-7251",
                            "email": "MCRCwebsitecontactform@stjoeshealth.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.36837,
                        "lon": -83.35271
                    }
                },
                {
                    "facility": "Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus",
                    "status": "RECRUITING",
                    "city": "Ypsilanti",
                    "state": "Michigan",
                    "zip": "48197",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "734-712-7251",
                            "email": "MCRCwebsitecontactform@stjoeshealth.org"
                        },
                        {
                            "name": "Justin Shaya",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.24115,
                        "lon": -83.61299
                    }
                },
                {
                    "facility": "Saint Francis Medical Center",
                    "status": "RECRUITING",
                    "city": "Cape Girardeau",
                    "state": "Missouri",
                    "zip": "63703",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "573-334-2230",
                            "email": "sfmc@sfmc.net"
                        },
                        {
                            "name": "Bryan A. Faller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.30588,
                        "lon": -89.51815
                    }
                },
                {
                    "facility": "Siteman Cancer Center at West County Hospital",
                    "status": "RECRUITING",
                    "city": "Creve Coeur",
                    "state": "Missouri",
                    "zip": "63141",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "800-600-3606",
                            "email": "info@siteman.wustl.edu"
                        },
                        {
                            "name": "Patrick Grierson",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.66089,
                        "lon": -90.42262
                    }
                },
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "800-600-3606",
                            "email": "info@siteman.wustl.edu"
                        },
                        {
                            "name": "Patrick Grierson",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Siteman Cancer Center-South County",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63129",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "800-600-3606",
                            "email": "info@siteman.wustl.edu"
                        },
                        {
                            "name": "Patrick Grierson",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Siteman Cancer Center at Christian Hospital",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "800-600-3606",
                            "email": "info@siteman.wustl.edu"
                        },
                        {
                            "name": "Patrick Grierson",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Siteman Cancer Center at Saint Peters Hospital",
                    "status": "RECRUITING",
                    "city": "Saint Peters",
                    "state": "Missouri",
                    "zip": "63376",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "800-600-3606",
                            "email": "info@siteman.wustl.edu"
                        },
                        {
                            "name": "Patrick Grierson",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.80033,
                        "lon": -90.62651
                    }
                },
                {
                    "facility": "OptumCare Cancer Care at Seven Hills",
                    "status": "RECRUITING",
                    "city": "Henderson",
                    "state": "Nevada",
                    "zip": "89052",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "702-384-0013",
                            "email": "research@sncrf.org"
                        },
                        {
                            "name": "John A. Ellerton",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.0397,
                        "lon": -114.98194
                    }
                },
                {
                    "facility": "OptumCare Cancer Care at Charleston",
                    "status": "RECRUITING",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89102",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "702-384-0013",
                            "email": "research@sncrf.org"
                        },
                        {
                            "name": "John A. Ellerton",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                },
                {
                    "facility": "OptumCare Cancer Care at Fort Apache",
                    "status": "RECRUITING",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89148",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "702-384-0013",
                            "email": "research@sncrf.org"
                        },
                        {
                            "name": "John A. Ellerton",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                },
                {
                    "facility": "Roswell Park Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Buffalo",
                    "state": "New York",
                    "zip": "14263",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "800-767-9355",
                            "email": "askroswell@roswellpark.org"
                        },
                        {
                            "name": "Sarbajit Mukherjee",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.88645,
                        "lon": -78.87837
                    }
                },
                {
                    "facility": "Glens Falls Hospital",
                    "status": "RECRUITING",
                    "city": "Glens Falls",
                    "state": "New York",
                    "zip": "12801",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "518-926-6700"
                        },
                        {
                            "name": "Charles Yun",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.30952,
                        "lon": -73.64401
                    }
                },
                {
                    "facility": "Miami Valley Hospital South",
                    "status": "RECRUITING",
                    "city": "Centerville",
                    "state": "Ohio",
                    "zip": "45459",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "937-528-2900",
                            "email": "clinical.trials@daytonncorp.org"
                        },
                        {
                            "name": "Tarek M. Sabagh",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.62839,
                        "lon": -84.15938
                    }
                },
                {
                    "facility": "Miami Valley Hospital",
                    "status": "RECRUITING",
                    "city": "Dayton",
                    "state": "Ohio",
                    "zip": "45409",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "937-528-2900",
                            "email": "clinical.trials@daytonncorp.org"
                        },
                        {
                            "name": "Tarek M. Sabagh",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.75895,
                        "lon": -84.19161
                    }
                },
                {
                    "facility": "Premier Blood and Cancer Center",
                    "status": "RECRUITING",
                    "city": "Dayton",
                    "state": "Ohio",
                    "zip": "45409",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "937-276-8320"
                        },
                        {
                            "name": "Tarek M. Sabagh",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.75895,
                        "lon": -84.19161
                    }
                },
                {
                    "facility": "Miami Valley Hospital North",
                    "status": "RECRUITING",
                    "city": "Dayton",
                    "state": "Ohio",
                    "zip": "45415",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "937-528-2900",
                            "email": "clinical.trials@daytonncorp.org"
                        },
                        {
                            "name": "Tarek M. Sabagh",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.75895,
                        "lon": -84.19161
                    }
                },
                {
                    "facility": "Atrium Medical Center-Middletown Regional Hospital",
                    "status": "RECRUITING",
                    "city": "Franklin",
                    "state": "Ohio",
                    "zip": "45005-1066",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "937-528-2900",
                            "email": "clinical.trials@daytonncorp.org"
                        },
                        {
                            "name": "Tarek M. Sabagh",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.55895,
                        "lon": -84.30411
                    }
                },
                {
                    "facility": "Miami Valley Cancer Care and Infusion",
                    "status": "RECRUITING",
                    "city": "Greenville",
                    "state": "Ohio",
                    "zip": "45331",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "937-569-7515"
                        },
                        {
                            "name": "Tarek M. Sabagh",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.10283,
                        "lon": -84.63301
                    }
                },
                {
                    "facility": "Upper Valley Medical Center",
                    "status": "RECRUITING",
                    "city": "Troy",
                    "state": "Ohio",
                    "zip": "45373",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "937-528-2900",
                            "email": "clinical.trials@daytonncorp.org"
                        },
                        {
                            "name": "Tarek M. Sabagh",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.0395,
                        "lon": -84.20328
                    }
                },
                {
                    "facility": "Saint Vincent Hospital Cancer Center Green Bay",
                    "status": "RECRUITING",
                    "city": "Green Bay",
                    "state": "Wisconsin",
                    "zip": "54301",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "920-433-8889",
                            "email": "ewd_research_admin@hshs.org"
                        },
                        {
                            "name": "Matthew L. Ryan",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.51916,
                        "lon": -88.01983
                    }
                },
                {
                    "facility": "Saint Vincent Hospital Cancer Center at Saint Mary's",
                    "status": "RECRUITING",
                    "city": "Green Bay",
                    "state": "Wisconsin",
                    "zip": "54303",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "920-433-8889",
                            "email": "ewd_research_admin@hshs.org"
                        },
                        {
                            "name": "Matthew L. Ryan",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.51916,
                        "lon": -88.01983
                    }
                },
                {
                    "facility": "Saint Vincent Hospital Cancer Center at Oconto Falls",
                    "status": "RECRUITING",
                    "city": "Oconto Falls",
                    "state": "Wisconsin",
                    "zip": "54154",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "920-433-8889",
                            "email": "ewd_research_admin@hshs.org"
                        },
                        {
                            "name": "Matthew L. Ryan",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.87388,
                        "lon": -88.14288
                    }
                },
                {
                    "facility": "Saint Vincent Hospital Cancer Center at Sheboygan",
                    "status": "RECRUITING",
                    "city": "Sheboygan",
                    "state": "Wisconsin",
                    "zip": "53081",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "920-433-8889",
                            "email": "ewd_research_admin@hshs.org"
                        },
                        {
                            "name": "Matthew L. Ryan",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.75083,
                        "lon": -87.71453
                    }
                },
                {
                    "facility": "Saint Vincent Hospital Cancer Center at Sturgeon Bay",
                    "status": "RECRUITING",
                    "city": "Sturgeon Bay",
                    "state": "Wisconsin",
                    "zip": "54235-1495",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Public Contact",
                            "role": "CONTACT",
                            "phone": "920-433-8889",
                            "email": "ewd_research_admin@hshs.org"
                        },
                        {
                            "name": "Matthew L. Ryan",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.83416,
                        "lon": -87.37704
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "\"NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.\"",
            "url": "https://grants.nih.gov/policy/sharing.htm"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000013274",
                    "term": "Stomach Neoplasms"
                },
                {
                    "id": "D000004938",
                    "term": "Esophageal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000013272",
                    "term": "Stomach Diseases"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "asFound": "Gastric Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "asFound": "Esophageal Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16062",
                    "name": "Stomach Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "asFound": "Gastric Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017239",
                    "term": "Paclitaxel"
                },
                {
                    "id": "D000077594",
                    "term": "Nivolumab"
                },
                {
                    "id": "D000068196",
                    "term": "Albumin-Bound Paclitaxel"
                },
                {
                    "id": "D000096662",
                    "term": "Ramucirumab"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000906",
                    "term": "Antibodies"
                },
                {
                    "id": "D000007136",
                    "term": "Immunoglobulins"
                },
                {
                    "id": "D000000911",
                    "term": "Antibodies, Monoclonal"
                },
                {
                    "id": "C000510234",
                    "term": "Lexatumumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000020533",
                    "term": "Angiogenesis Inhibitors"
                },
                {
                    "id": "D000043924",
                    "term": "Angiogenesis Modulating Agents"
                },
                {
                    "id": "D000006133",
                    "term": "Growth Substances"
                },
                {
                    "id": "D000006131",
                    "term": "Growth Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "asFound": "Use",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19537",
                    "name": "Paclitaxel",
                    "asFound": "Dose Escalation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M231",
                    "name": "Albumin-Bound Paclitaxel",
                    "asFound": "Dose Escalation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1854",
                    "name": "Nivolumab",
                    "asFound": "Technique",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "asFound": "Use",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4230",
                    "name": "Antibodies, Monoclonal",
                    "asFound": "Double-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3246",
                    "name": "Ramucirumab",
                    "asFound": "Platelet count",
                    "relevance": "HIGH"
                },
                {
                    "id": "M289520",
                    "name": "Lexatumumab",
                    "asFound": "LY2605541",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "asFound": "Double-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19117",
                    "name": "Immunoglobulins, Intravenous",
                    "relevance": "LOW"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M22318",
                    "name": "Angiogenesis Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}